Wall Street Cuts Mosaic Company Again: UBS Slashes Target to $27

The Mosaic Company (NYSE:MOS) received a downgrade from UBS on Thursday, as analyst Lucas Beaumont cut his rating to Neutral from Buy and slashed his price target to $27 from $33. The move reflects a structural squeeze on phosphate profitability — one that multiple Wall Street firms have now flagged in rapid succession.

The Analyst’s Case

UBS sees the risk/reward as more balanced at current share levels after a cascade of margin headwinds hit the phosphate business. The core problem: elevated sulfur and ammonia input costs, exacerbated by Middle East supply disruptions, are compressing stripping margins. Beaumont also flags that improvements in phosphate production have been slow, limiting fixed cost absorption and Mosaic’s ability to capitalize on high prices.

The earnings data backs this up. Phosphate cash cost of conversion climbed to $131 per tonne in Q3 2025, up from $101 in the prior year. The Q4 earnings call added urgency: sulfur prices spiked to roughly $500 per metric ton late in the quarter, and management guided for an approximately $250 million EBITDA headwind in Q1 2026 as a result. CEO Bruce Bodine acknowledged the severity directly: “When sulfur prices spiked at the end of the year, which we expect will significantly compress margins in our Phosphate and Mosaic Fertilizantes segments well into the first half of 2026, we moved quickly to protect margins and profitability.”

Multiple Wall Street firms share UBS’s reassessment. Bank of America also downgraded Mosaic to Neutral in late March, lowering its price target to $30 from $33 and citing delayed margin expansion now expected in 2027 rather than 2026. Freedom Capital Markets and Barclays also downgraded the stock around the same period.

Why the Move Matters Now

Mosaic shares closed at $26.19 on March 25, essentially in line with UBS’s new $27 target and well below the 52-week high of $37.31. The stock has dropped 8.1% over the past month, with much of that damage concentrated around the BofA downgrade. Free cash flow turned negative at -$135 million in Q3 2025, driven by higher working capital and elevated capex, and management guided for approximately $1.5 billion in capital expenditures in 2026.

The broader analyst consensus sits at a mean price target of $31.69, with nine analysts at Hold and six at Buy — suggesting the Street as a whole remains more constructive than UBS, but the direction of revisions is clearly downward.

What It Means for Your Portfolio

Long-term structural tailwinds remain intact — Chinese phosphate export restrictions, growing LFP battery demand, and potash supply constraints all support Mosaic’s core business over time. But near-term, the combination of sulfur-driven margin compression, negative free cash flow, and slow production ramp leaves limited near-term upside. The $0.22 quarterly dividend provides some income support, but investors seeking a catalyst for re-entry may need to wait for evidence that sulfur costs have normalized and phosphate conversion costs are tracking toward management’s long-term target of below $100 per tonne.